Congratulations to RIW Client, CereVasc, on successfully entering into a new lease for office, light manufacturing, and R&D at 200 Ballardvale Street, Wilmington, MA. CereVasc is a medical device company focused on developing novel, minimally invasive treatments for patients with neurological diseases.
It was a pleasure working with the CereVasc team, as well as Matthew Daniels and his colleagues at JLL, Carly Kiernan and Griffin Zink. Michael Rosen led RIW’s legal team on this transaction. Learn more about the services of our Commercial Real Estate team here.
